Targeting SARM1 and Axon Degeneration as a Design-Modifying Strategy for the Treatment of CMT2A
48:52
A remoção do SARM1 pode levar a uma terapia para pacientes com CMT2A?
16:58
Targeting Cytosolic HDAC6 Inhibition for the Treatment of CMT and Beyond
35:15
Entendendo o CRISPR-Cas9
48:55
Genetics of CMT: One Name, Many Diseases with Shawna Feely, University of Iowa
1:17:41